摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-TTT-TT-3' | 17708-74-6

中文名称
——
中文别名
——
英文名称
5'-TTT-TT-3'
英文别名
single-stranded dT5;[(2R,3S,5R)-3-[hydroxy-[[(2R,3S,5R)-3-[hydroxy-[[(2R,3S,5R)-3-[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl [(2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] hydrogen phosphate
5'-TTT-TT-3'化学式
CAS
17708-74-6
化学式
C50H66N10O33P4
mdl
——
分子量
1459.02
InChiKey
SNTINBZZQZEOPH-OPOFJALESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -7.9
  • 重原子数:
    97
  • 可旋转键数:
    26
  • 环数:
    10.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    557
  • 氢给体数:
    11
  • 氢受体数:
    33

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Sensor with a scaffold having changeable conformations
    摘要:
    这项发明涉及一种具有包含药物的容器的支架传感器,用于触发药物释放,其中支架在本质上构象亚稳,并提供了一种制造方法。
    公开号:
    US09758545B2
  • 作为产物:
    描述:
    3’-O-(4,4’-二甲氧基三苯甲基)胸苷4-二甲氨基吡啶 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 生成 5'-TTT-TT-3'
    参考文献:
    名称:
    核苷酸,第 LXV 部分,2'-脱氧核糖核苷 5'-亚磷酰胺的合成:反向 (5'-3')-寡核苷酸方法的新构件
    摘要:
    The syntheses of the 3'-O-(4,4'-dimethoxytrityl)-protected 5'-phosphoramidites 25-28 and 5'-(hydrogen succinates) 29-32, which can be used as monomeric building blocks for the inverse (5'-3')-oligodeoxyribonucleotide synthesis are described (Scheme). These activated nucleosides and nucleotides were obtained by two slightly different four-step syntheses starting with the base-protected nucleosides 13-20. For the protection of the aglycon residues, the well-established 2-(4-nitrophenyl)ethyl (npe) and [2-(4-nitrophenyl)ethoxy]carbonyl (npeoc) groups were used. The assembly of the oligonucleotides required a slightly increased coupling time of 3 min in application of the common protocol (see Table 1). The use of pyridinium hydrochloride as an activator (instead of 1H-tetrazole) resulted in an extremely shorter activation time of 30 seconds. We established the efficiency of this inverse strategy by the synthesis of the oligonucleotide 3'-conjugates 33 and 34 which carry lipophilic caps derived from cholesterol and vitamin E, respectively, as well as by the formation of (3'-3')- and (5'-5')-internucleotide linkages (see Table 2).
    DOI:
    10.1002/1522-2675(20000809)83:8<2023::aid-hlca2023>3.0.co;2-p
点击查看最新优质反应信息

文献信息

  • Design, Synthesis, and Cellular Uptake of Oligonucleotides Bearing Glutathione-Labile Protecting Groups
    作者:Hisao Saneyoshi、Takayuki Ohta、Yuki Hiyoshi、Takeo Saneyoshi、Akira Ono
    DOI:10.1021/acs.orglett.8b03501
    日期:2019.2.15
    Glutathione-labile protecting groups for phosphodiester moieties in oligonucleotides were designed, synthesized, and incorporated into oligonucleotides. The protecting groups on the phosphodiester moieties were cleaved in a buffer containing 10 mM glutathione, which was used as a model of intracellular fluid. Cellular uptake of oligonucleotides bearing glutathione-labile protecting groups was strongly affected
    设计,合成并合成寡核苷酸中对寡核苷酸中的磷酸部分的谷胱甘肽不稳定的保护基。在含有10mM谷胱甘肽缓冲液中裂解磷酸部分上的保护基,该缓冲液用作细胞内液的模型。带有谷胱甘肽不稳定的保护基的寡核苷酸的细胞摄取受到保护基团的位置和数量的强烈影响。
  • Prebiotic Phosphorylation and Concomitant Oligomerization of Deoxynucleosides to form DNA
    作者:Eddy I. Jiménez、Clémentine Gibard、Ramanarayanan Krishnamurthy
    DOI:10.1002/anie.202015910
    日期:2021.5.3
    RNA and DNA replication, coupled with prebiotic co‐synthesis of deoxyribo‐ and ribo‐nucleotides, have resurrected the hypothesis of co‐emergence of RNA and DNA. As further support, we show that diamidophosphate (DAP) with 2‐aminoimidazole (amido)phosphorylates and oligomerizes deoxynucleosides to form DNA—under conditions similar to those of ribonucleosides. The pyrimidine deoxynucleoside 5′‐O‐amidophosphates
    最近展示的 RNA-DNA 嵌合体 (RDNA) 使 RNA 和 DNA 复制成为可能,再加上核糖核糖核苷酸的益生元共合成,重新提出了 RNA 和 DNA 共生的假设。作为进一步的支持,我们表明二酰胺磷酸 (DAP) 与 2-氨基咪唑酰胺基)磷酸化并寡聚化核苷以形成 DNA——在与核糖核苷相似的条件下。嘧啶核苷 5'-O-磷酸以良好的 (≈60%) 产率形成。有趣的是,嘧啶核苷(酸)苷的存在增加了嘌呤核苷酸的产量(≈20%)。同时,观察到寡聚化 (≈18–31%) 主要是 3',5'-磷酸 DNA 键和一些 (<5%) 焦磷酸盐。
  • Synthesis of oligodeoxynucleotides using the oxidatively cleavable 4-methoxytritylthio (MMTrS) group for protection of the 5′-hydroxyl group
    作者:Kohji Seio、Miyuki Shiraishi、Eri Utagawa、Akihiro Ohkubo、Mitsuo Sekine
    DOI:10.1039/b9nj00678h
    日期:——
    We examined the synthesis of oligodeoxynucleotides containing all four nucleobases using the 4-methoxytritylthio (MMTrS) group for protection of the 5′-hydroxyl group. The MMTrS group could be introduced into 3′-O-TBDMS-deoxycytidine, -deoxyadenosine and -deoxyguanosine with the appropriate base protecting groups using strong bases such as n-butyl lithium and lithium hexamethyldisilazide. Because the
    我们使用4-甲氧基甲基基(MMTrS)基团来保护5'-羟基,研究了包含所有四个核碱基的寡核苷酸的合成。MMTrS组可以引入3'- O -TBDMS-胞苷, -腺苷 和 -鸟苷 带有适当的碱保护基团,并使用强碱,例如 正丁基锂 和 六甲基叠氮。因为MMTrS基团可通过用I 2溶液化而除去,所以核苷酸间的亚磷酸中间体可以同时进行。因此,核苷酸链可以以包括偶联,加帽和化/保护的三步方案进行延伸。可以使用此协议合成具有10和20个混合碱基序列的寡核苷酸
  • Bioreductive deprotection of 4-nitrobenzyl group on thymine base in oligonucleotides for the activation of duplex formation
    作者:Hisao Saneyoshi、Yuki Hiyoshi、Koichi Iketani、Kazuhiko Kondo、Akira Ono
    DOI:10.1016/j.bmcl.2015.10.025
    日期:2015.12
    Oligonucleotides containing 4-O-(4-NO2-benzyl)thymine residues were synthesized to assess potential prodrug-type action against hypoxic cells. These modified oligonucleotides were incapable of stable duplex formation under non-hypoxic conditions. However, following deprotection of the thymine residues under bioreductive conditions, the deprotected oligonucleotides were able to form stable duplexes with target oligonucleotides. (C) 2015 Elsevier Ltd. All rights reserved.
  • MAKINO, KEISUKE;MURAKAMI, AKIRA;NAGAHARA, SHUNJI;NAKATSUJI, YUNA;TAKEUCHI+, 15TH SYMP. NUCL. ACIDS CHEM., SAPPORO, SEPT. 19TH - 21ST, 1988, OXFORD; W+
    作者:MAKINO, KEISUKE、MURAKAMI, AKIRA、NAGAHARA, SHUNJI、NAKATSUJI, YUNA、TAKEUCHI+
    DOI:——
    日期:——
查看更多

同类化合物

马来酸恩替卡韦 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺式5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮-13C,15N2 顺-5-氟-1-[2-[[[[(((1,1-二甲基乙基)二甲基甲硅烷基]氧基]甲基]-1,3-氧杂硫杂环戊-5-基]-2,4(1H,3H)-嘧啶二酮 阿巴卡韦羧酸盐 阿巴卡韦相关物质D 阿巴卡韦杂质F 阿巴卡韦杂质 阿巴卡韦中间体A5 阿巴卡韦5’-磷酸酯 阿巴卡韦,拉米夫定混合物 阿巴卡韦 阿巴卡韦 铁(2+)乙二酸酯-丁烷-1-胺(1:1:2) 贝伐西尼 苯甲酸,3-(2-氨基-2-氰基乙酰基)-,乙基酯 芒霉素 艾夫他滨 腺苷基(3'-5')胞苷基(3'-5')胞苷游离酸 腺苷-3',5'-环硫代磷酸酯 腺苷-2',3'-环单硫代磷酸酯,盐内/RP-同质异能素钠 脱氧假尿苷 胸苷酰-(5'-3')-胸苷酰-(5'-3')-胸苷酰-(5'-3')-5'-胸苷酸 胰腺癌RX-3117 硫酸阿巴卡韦 甲基磷羧酸氢[(2S,5R)-5-(4-氨基-2-羰基嘧啶-1(2H)-基)-2,5-二氢呋喃-2-基]甲酯 瓶型酵母D 瓶型酵母A 环戊烯基尿嘧啶 水杨酸拉米呋啶 氟达拉滨EP杂质H 曲沙他滨 拉米夫定相关化合物(Α-TROXACITABINE) 拉米夫定杂质Ⅲ1-[(2R,5S)-2-羟甲基-1,3-氧硫杂环戊-5-基]-嘧啶-2,4(1H,3H)-酮 拉米夫定杂质27 拉米夫定杂质1 拉米夫定单磷酸铵盐 拉米夫定二磷酸酯铵盐 拉米夫定S-氧化物(异构体混合物) 拉米夫定 拉米夫定 拉夫米定EP杂质J 拉夫米定EP杂质H 扎西他宾 恩替卡韦相关物质A 恩替卡韦杂质SSS 恩替卡韦一水合物 恩曲他滨杂质16 恩曲他滨S-氧化物